Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carboplatin and Paclitaxel for Recurrent or Metastatic Nasopharyngeal Carcinoma
NCT00003206Phase 2Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Oct 1999
- Primary completion
- Jul 2001
- Modality
- DNA Intercalators/Alkylators
- Countries
- 2
01
Overview
A Phase 2 trial of carboplatin, paclitaxel in nasopharyngeal carcinoma (NPC), sponsored by Eastern Cooperative Oncology Group. Started Oct 1999; status: completed.
02
Drugs
carboplatinpaclitaxel
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT00003206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003206.